Agile Therapeutics, Inc. (Nasdaq: AGRX) announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All shares being offered are to be sold by Agile Therapeutics. Agile Therapeutics intends to grant the underwriters a 30-day option to purchase an additional fifteen percent of the shares of common stock offered in the public offering. The proposed offering is subject to market and other conditions, and there can be no assurances as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

The joint book-running managers for the offering are RBC Capital Markets, William Blair and Oppenheimer & Co. In addition, H.C. Wainwright & Co., Maxim Group LLC, and Janney Montgomery Scott are acting as co-managers.